Cite
HARVARD Citation
Gisslinger, H. et al. (2019). A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM‐ET 2·0 trial. British journal of haematology. pp. 691-700. [Online].